PROTECTED SOURCE SCRIPT
Mis à jour

Companion::Insurgent

960
Companion::Insurgent is a combined indicators strategy. Performances are pretty good on 1D, 4H and 1H timeframes and it can be used on Bitcoin and Altcoin markets.


Mainly, it is a trategy based on Ehlers formulas.


Used indicators:

- Ehlers Instantaneous Trend: trendline analysis;
- Ehlers Super Bandpass Filter: momentum detection;
- EMA: Long/Short time selector.


What the script does:

- determines trendlines combining mulitple indicators;
- automaticlally calculates Take profit and Stop Loss levels;
- permits automation generating Autoview signals (create an alert with {{strategy.order.alert_message}} in message text field to trap Autoview commands;
- supports for margin trading. Spot trading will be added in the future.



BACKTESTING

Backtest is not leveraged. Defaults are set as follow:

Capital: 10000
Percent of equity used for trades: 10%
Commission: 0.18% this is Bitfinex commission on orders


Change them accordingly on how you trade to get a more realistic backtest results.
Notes de version

Changes:

- Added parameter to set percentage of Equity to trade
Notes de version
Changes:

- Autoview support for BTC 10x leverage on Bitfinex
- Cosmetic changes
Notes de version
Changes:

- Added Heartbeat and Status Info option;
- Now Autoview commands and messages are managed using new reliable and transparent Pine Script alert() function.

FYI: please note that every time you update a strategy or change strategy parameters you will need to create a new Alert and delete the old one, otherwise the old Alert will continue to work with the old setup.
Notes de version
Changes:

- Added some new options;
- Revamped parameters tab.
Notes de version
Changes:
- strategy improvements;
- cosmetic changes.
Notes de version
Changes:

- cosmetic changes;
- removed transp argument, soon deprecated in pine script.
Notes de version
Changes:

- added new filters;
- added ability to apply trailing stops to Longs, Shorts or both.

Clause de non-responsabilité

Les informations et les publications ne sont pas destinées à être, et ne constituent pas, des conseils ou des recommandations en matière de finance, d'investissement, de trading ou d'autres types de conseils fournis ou approuvés par TradingView. Pour en savoir plus, consultez les Conditions d'utilisation.